What does CUSIP 14159U301 represent in this 13F holders report?

CUSIP 14159U301 is the security identifier for CRME - CARDIOME PHARMA CORP - COM NO PAR used to aggregate holder disclosures.

How many institutions held CRME - CARDIOME PHARMA CORP - COM NO PAR in Q2 2017?

25 institutional investors reported CRME - CARDIOME PHARMA CORP - COM NO PAR for Q2 2017. Use the holders table for investor-level position and value details.

CARDIOME PHARMA CORP - COM NO PAR (CRME)

CUSIP: 14159U301

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / COM NO PAR
Total 13F shares: 18,631,444
Share change: -202
Total reported value: $84,209,221
Put/Call ratio: 410%
Price per share: $4.51
Number of holders: 25
Value change: +$511,329
Number of buys: 11
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 14159U301?
CUSIP 14159U301 identifies CRME - CARDIOME PHARMA CORP - COM NO PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 14159U301:

Q2 2018 Q1 2018 Q4 2017 Q3 2017 Q2 2017 Q1 2017 Q4 2016 Q3 2016

Institutional Holders of CARDIOME PHARMA CORP - COM NO PAR (CRME) as of Q2 2017

As of 30 Jun 2017, CARDIOME PHARMA CORP - COM NO PAR (CRME) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,631,444 shares. The largest 10 holders included WESTFIELD CAPITAL MANAGEMENT CO LP, PUTNAM INVESTMENTS LLC, CLOUGH CAPITAL PARTNERS L P, Tamarack Advisers, LP, Stonepine Capital Management, LLC, Rock Springs Capital Management LP, AlphaOne Investment Services, LLC, RENAISSANCE TECHNOLOGIES LLC, JPMORGAN CHASE & CO, and Knott David M. This page lists 25 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.